Chimeric protein in the treatment of amyloidosis
US11345730B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 11, 2018 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | May 11, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a chimeric protein comprising at least one human amyloid P component and at least one fragment of an Fc region of a human antibody, the human amyloid P component and the fragment of an Fc region with which it is associated being bound to each other by means of a hinge region.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.